A long term efficacy of PRRT in patients with advanced, non- resectable paraganglioma/pheochromocytoma tumours, related to SDHx gene mutation

被引:0
|
作者
Kolasinska-Cwikla, A. D. [1 ,2 ]
Peczkowska, M. [3 ]
Michalowska, I. [3 ]
Lewczuk, A. [4 ]
Bodei, L. [5 ]
Kidd, M. [6 ]
Modlin, I. M. [7 ]
Cwikla, J. B. [8 ]
机构
[1] MSC Mem Canc Ctr, Warsaw, Poland
[2] Inst Maria Sklodowska Curie, Warsaw, Poland
[3] Inst Cardiol, Warsaw, Poland
[4] Med Univ Gdansk, Gdansk, Poland
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[6] Wren Lab, Branford, CT USA
[7] Yale Univ, New Haven, CT USA
[8] Univ Warmia & Mazury, Fac Med Sci, Olsztyn, Poland
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EP-0807
引用
收藏
页码:S775 / S775
页数:1
相关论文
共 40 条
  • [1] A Clinical Efficacy of PRRT in Patients with Advanced, Nonresectable, Paraganglioma-Pheochromocytoma, Related to SDHx Gene Mutation
    Kolasinska-Cwikla, Agnieszka
    Peczkowska, Mariola
    Cwikla, Jaroslaw B.
    Michalowska, Ilona
    Palucki, Jakub M.
    Bodei, Lisa
    Lewczuk-Myslicka, Anna
    Januszewicz, Andrzej
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (07):
  • [2] Clinical, long term efficacy of PRRT in NEN patients with advanced, nonresectable, progressive hindgut and cancer of unknown primary (CUP)
    Kolasinska-Cwikla, A. D.
    Lewczuk, A.
    Bodei, L.
    Kidd, M.
    Buscombe, J. R.
    Modlin, I. M.
    Cwikla, J. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S286 - S287
  • [3] Safety and efficacy of long-term exposure (LTE) to tislelizumab in Chinese patients with advanced solid tumours
    Shen, L.
    Wu, Y-L.
    Yuan, Y.
    Bai, Y.
    Zhang, Q.
    Zhou, Q.
    Liu, T.
    Zhao, J.
    Wang, S.
    Huang, X.
    Pan, H.
    Zhou, A.
    Sun, T.
    Wang, J.
    Gao, Y.
    Yang, S.
    Li, Y.
    Zhang, J.
    Guo, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S478 - S479
  • [4] Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials
    Severi, S.
    Bongiovanni, A.
    Ferrara, M.
    Nicolini, S.
    Di Mauro, F.
    Sansovini, M.
    Lolli, I.
    Tardelli, E.
    Cittanti, C.
    Di Iorio, V.
    Mezzenga, E.
    Scarpi, E.
    Ibrahim, T.
    Paganelli, G.
    Zovato, S.
    ESMO OPEN, 2021, 6 (04)
  • [5] Long term survival analysis after i.a. 90Y-DOTATATE PRRT, in patients with non-resectable, advance progressive liver dominant neuroendocrine neoplasms
    Nowicki, M. L.
    Konsek, S. J.
    Jaskiewicz, L.
    Mol, M.
    Sankowski, A.
    Buscombe, J. R.
    Bodei, L.
    Mikolajczak, R.
    Cwikla, J. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S82 - S82
  • [6] Long-term outcome of indigenous 177Lu-DOTATATE PRRT in patients with Metastatic Advanced Neuroendocrine Tumours: a single institutional observation in a large tertiary care setting
    Sitani, Keerti
    Parghane, Rahul, V
    Talole, Sanjay
    Basu, Sandip
    BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1117):
  • [7] Perioperative nivolumab results in favourable long-term outcomes in patients with locally advanced resectable non-small-cell lung cancer
    Cascone, Tina
    William Jr, William N.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2025, 22 (02) : 81 - 82
  • [8] Correlation of gefitinib efficacy and detection of new EGFR mutation variants in pre-treated patients (pts) with advanced non- small cell lung cancer (NSCLC)
    Pallis, A.
    Voutsina, A.
    Kalikaki, A.
    Koutsopoulos, A.
    Souglakos, J.
    Christophylakis, C.
    Kentepozidis, N.
    Giassas, S.
    Mavroudis, D.
    Georgoulias, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Long-Term Follow-Up of Advanced Paraganglioma Patients Treated With 177Lu-Dotatate or 90Y-Dotatoc PRRT in Phase-II Perspective Protocols: Activity And Toxicity Reports
    Severi, S.
    Zovato, S.
    Di Mauro, F.
    Ferrara, A. M.
    Nicolini, S.
    Tardelli, E.
    Bongiovanni, A.
    Di Iorio, V.
    Mezzenga, E.
    Scarpi, E.
    Turri, V.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S185 - S185
  • [10] UPDATED LONG-TERM SURVIVAL AND SAFETY FROM A MULTI-CENTER, OPEN-LABEL, PIVOTAL PHASE 2 STUDY OF AZEDRA® IN PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC PHEOCHROMOCYTOMA OR PARAGANGLIOMA
    Jimenez, Camilo
    Chin, Bennett B.
    Noto, Richard B.
    Dillon, Joseph S.
    Solnes, Lilja
    DiPippo, Vincent A.
    Stambler, Nancy
    Wong, Vivien
    Pryma, Daniel A.
    JOURNAL OF UROLOGY, 2020, 203 : E632 - E632